BIOTECON THERAPEUTICS GMBH has a total of 34 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Brazil, Canada and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are INTELLECT NEUROSCIENCES INC, KOCHER THEODOR INST and BIOMARCK PHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 4 | |
#2 | Canada | 4 | |
#3 | Republic of Korea | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | China | 3 | |
#6 | EPO (European Patent Office) | 3 | |
#7 | Germany | 2 | |
#8 | Israel | 2 | |
#9 | Mexico | 2 | |
#10 | Norway | 2 | |
#11 | United States | 2 | |
#12 | Australia | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Frevert Juergen | 20 |
#2 | Specht Volker | 13 |
#3 | Stibora Thomas | 9 |
#4 | Frevert Jurgen | 4 |
#5 | Juergen Frevert | 3 |
#6 | Volker Specht | 1 |
#7 | Bigalke Hans | 1 |
#8 | Thomas Stibora | 1 |
Publication | Filing date | Title |
---|---|---|
EP1834962A1 | PEGylated mtutated Clostridium botulinum toxin | |
DE102004035606A1 | Carrier for drugs for obtaining oral bioavailability | |
DE10333317A1 | Formulation for protein medicines without the addition of human serum albumin (HSA) | |
US2003059912A1 | Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |